Grossi Federico 4
4 · Apellis Pharmaceuticals, Inc. · Filed Oct 5, 2022
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-10-03$66.69/sh−2,500$166,725→ 102,384 total
Footnotes (1)
- [F1]This is a scheduled sale from 10b5-1 trading plan.